Biocon Biologics Ltd 2025 Integrated Report
Company: Biocon Biologics Ltd
Sector: Manufacturing
Country: India
Year: 2025
Type: Integrated Report
Pages: 305
The report presents Biocon Biologics' FY25 performance as a year of consolidation, global reach, and expanded access to affordable biosimilars. The company reported consolidated revenue of 90,174 INR million and reached more than 5.8 million patients worldwide. Sustainability highlights include 77% renewable power usage in India operations, 43% renewable power in global operations, and 95% waste disposed through circularity. ESG oversight is formalized through a CSR and ESG Board Committee responsible for the company's sustainability agenda.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.